{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-113291","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.922139+00:00","generated_at":"2026-05-22T11:51:21.777919+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Viridian Q1 cash $636.6M; veligrotug BLA on track for H2 2025","bullets":["Cash, cash equivalents, and short-term investments $636.6M at March 31, 2025, down from $717.6M in December 2024; runway into H2 2027.","R&D expenses $76.8M in Q1 2025 vs $40.9M in Q1 2024, driven by more clinical trials and increased headcount.","Veligrotug BLA submission to FDA on track for H2 2025; EMA MAA expected in H1 2026.","Phase 3 topline data for VRDN-003 (subcutaneous TED) expected H1 2026 from REVEAL-1 and REVEAL-2 trials.","VRDN-006 phase 1 healthy volunteer data expected Q3 2025; VRDN-008 IND submission targeted for year-end 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-113291","json":"https://secwatch.observer/filing/0001193125-25-113291.json","markdown":"https://secwatch.observer/filing/0001193125-25-113291.md","text":"https://secwatch.observer/filing/0001193125-25-113291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525113291/0001193125-25-113291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525113291/d937417d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T11:51:21.777919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}